| dc.contributor.author | Küçükerdönmez F.C. | |
| dc.contributor.author | Akova Y. | |
| dc.contributor.author | Aksoy S. | |
| dc.contributor.author | Süllü Y. | |
| dc.date.accessioned | 2020-06-21T09:27:34Z | |
| dc.date.available | 2020-06-21T09:27:34Z | |
| dc.date.issued | 2010 | |
| dc.identifier.issn | 1300-1256 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/4100 | |
| dc.description.abstract | Punctate inner choroidopathy is an idiopathic, inflammatory disorder that is characterized by yellowish white spots at the level of retina pigment epithelium and inner choroid. It is associated with a high incidence of choroidal neovascularization (CNV). Vision loss occurs mainly due to CNV development, and treatment options include systemic steroids, laser photocoagulation, interferon ?1?, and submacular surgery. We report a case of punctate inner choroidopathy and discuss the results of intravitreal bevacizumab treatment for CNV. | en_US |
| dc.language.iso | tur | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Bevacizumab | en_US |
| dc.subject | Choroidal neovascularization | en_US |
| dc.subject | Punctate inner choroidopathy | en_US |
| dc.title | Intravitreal bevacizumab in a case of choroidal neovascularization associated with punctate inner choroidopathy | en_US |
| dc.title.alternative | Noktasal i?ç koroidopati'ye bağli koroidal neovaskülarizasyon gelişen bir olguda vitre i?çi bevacizumab tedavisi | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 18 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.identifier.startpage | 163 | en_US |
| dc.identifier.endpage | 166 | en_US |
| dc.relation.journal | Retina-Vitreus | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
